Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Efficacy and Safety of Tangningtongluo Tablet in Treating Non Proliferative Diabetic Retinopathy - The Syndrome of Yin Asthenia Generating Intrinsic Heat and Eye Collateral Stasis

NCT05007262 is registered in ClinicalTrials.gov with Guizhou Bailing Group Pharmaceutical Co Ltd as lead sponsor.

NCT NCT05007262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05007262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Efficacy and Safety of Tangningtongluo Tablet in Treating Non Proliferative Diabetic Retinopathy - The Syndrome of Yin Asthenia Generating Intrinsic Heat and Eye Collateral Stasis
Lead sponsor
Guizhou Bailing Group Pharmaceutical Co Ltd
Phase
Phase 2
Overall status
Unknown status
Start date
August 31, 2021
Completion date
December 31, 2023
Enrollment
240 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy, type2 diabetes